首页 > 最新文献

Annals Academy of Medicine Singapore最新文献

英文 中文
Concordance of self-reporting of diabetes compared with medical records: A comparative study using polyclinic data in Singapore. 糖尿病自我报告与医疗记录的一致性:新加坡综合诊所数据的比较研究。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.47102/annals-acadmedsg.2022246
Khai Wei Tan, Jeremy Kaiwei Lew, P. S. Lee, Sin Kee Ong, Hui Li Koh, D. Young, Eng Sing Lee
INTRODUCTIONStudies of concordance between patients' self-report of diseases and a criterion standard (e.g. chart review) are usually conducted in epidemiological studies to evaluate the agreement of self-reported data for use in public health research. To our knowledge, there are no published studies on concordance for highly prevalent chronic diseases such as diabetes and pre-diabetes. The aims of this study were to evaluate the concordance between patients' self-report and their medical records of diabetes and pre-diabetes diagnoses, and to identify factors associated with diabetes concordance.METHODA cross-sectional, interviewer-administered survey was conducted on patients with chronic diseases after obtaining written consent to assess their medical notes. Interviewers were blinded to the participants' profiles. Concordance was evaluated using Cohen's kappa (κ). A multivariable logistic regression model was used to identify factors associated with diabetes concordance.RESULTSThere was substantial agreement between self-reported and medical records of diabetes diagnoses (κ=0.76) and fair agreement for pre-diabetes diagnoses (κ=0.36). The logistic regression model suggested that non-Chinese patients had higher odds of diabetes concordance than Chinese patients (odds ratio [OR]=4.10, 95% confidence interval [CI] 1.19-14.13, P=0.03). Patients with 3 or more chronic diseases (i.e. multimorbidity) had lower odds of diabetes concordance than patients without multimorbidity (OR=0.21, 95% CI 0.09-0.48, P<0.001).CONCLUSIONDiabetes concordance was substantial, supporting the use of self-report of diabetes by patients with chronic diseases in the primary care setting for future research. Pre-diabetes concordance was fair and may have important clinical implications. Further studies to explore and improve health literacy and patient-physician communication are needed.
在流行病学研究中,通常对患者疾病自我报告与标准(如图表审查)之间的一致性进行研究,以评估用于公共卫生研究的自我报告数据的一致性。据我们所知,目前还没有关于高流行慢性病如糖尿病和前驱糖尿病的一致性的发表研究。本研究的目的是评估患者自我报告与糖尿病和糖尿病前期诊断之间的一致性,并确定糖尿病一致性的相关因素。方法在获得慢性病患者的书面同意后,对其医疗记录进行横断面、访谈者管理的调查。面试官对参与者的个人资料一无所知。采用Cohen’s kappa (κ)评价一致性。采用多变量logistic回归模型确定与糖尿病一致性相关的因素。结果自述的糖尿病诊断与病历的糖尿病诊断基本一致(κ=0.76),糖尿病前期诊断与病历的糖尿病诊断基本一致(κ=0.36)。logistic回归模型显示,非中国籍患者糖尿病一致性的发生率高于中国籍患者(优势比[OR]=4.10, 95%可信区间[CI] 1.19 ~ 14.13, P=0.03)。患有3种或3种以上慢性疾病(即多重疾病)的患者与没有多重疾病的患者相比,糖尿病一致性的几率较低(or =0.21, 95% CI 0.09-0.48, P<0.001)。结论糖尿病的一致性是显著的,支持慢性病患者在初级保健机构中使用糖尿病自我报告进行未来的研究。糖尿病前期的一致性是公平的,可能具有重要的临床意义。需要进一步的研究来探索和提高健康素养和医患沟通。
{"title":"Concordance of self-reporting of diabetes compared with medical records: A comparative study using polyclinic data in Singapore.","authors":"Khai Wei Tan, Jeremy Kaiwei Lew, P. S. Lee, Sin Kee Ong, Hui Li Koh, D. Young, Eng Sing Lee","doi":"10.47102/annals-acadmedsg.2022246","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022246","url":null,"abstract":"INTRODUCTION\u0000Studies of concordance between patients' self-report of diseases and a criterion standard (e.g. chart review) are usually conducted in epidemiological studies to evaluate the agreement of self-reported data for use in public health research. To our knowledge, there are no published studies on concordance for highly prevalent chronic diseases such as diabetes and pre-diabetes. The aims of this study were to evaluate the concordance between patients' self-report and their medical records of diabetes and pre-diabetes diagnoses, and to identify factors associated with diabetes concordance.\u0000\u0000\u0000METHOD\u0000A cross-sectional, interviewer-administered survey was conducted on patients with chronic diseases after obtaining written consent to assess their medical notes. Interviewers were blinded to the participants' profiles. Concordance was evaluated using Cohen's kappa (κ). A multivariable logistic regression model was used to identify factors associated with diabetes concordance.\u0000\u0000\u0000RESULTS\u0000There was substantial agreement between self-reported and medical records of diabetes diagnoses (κ=0.76) and fair agreement for pre-diabetes diagnoses (κ=0.36). The logistic regression model suggested that non-Chinese patients had higher odds of diabetes concordance than Chinese patients (odds ratio [OR]=4.10, 95% confidence interval [CI] 1.19-14.13, P=0.03). Patients with 3 or more chronic diseases (i.e. multimorbidity) had lower odds of diabetes concordance than patients without multimorbidity (OR=0.21, 95% CI 0.09-0.48, P<0.001).\u0000\u0000\u0000CONCLUSION\u0000Diabetes concordance was substantial, supporting the use of self-report of diabetes by patients with chronic diseases in the primary care setting for future research. Pre-diabetes concordance was fair and may have important clinical implications. Further studies to explore and improve health literacy and patient-physician communication are needed.","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 2 1","pages":"62-70"},"PeriodicalIF":5.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45529328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and effectiveness of nitrous oxide procedural sedation in a paediatric emergency department. 儿科急诊科一氧化二氮程序镇静的安全性和有效性。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.47102/annals-acadmedsg.2022195
S. Tan, L. P. Tham
{"title":"Safety and effectiveness of nitrous oxide procedural sedation in a paediatric emergency department.","authors":"S. Tan, L. P. Tham","doi":"10.47102/annals-acadmedsg.2022195","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022195","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 2 1","pages":"100-104"},"PeriodicalIF":5.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44106518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes: Know thy foe. 糖尿病:了解你的敌人。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-02-01
Peng Yong Andrew Wong
{"title":"Diabetes: Know thy foe.","authors":"Peng Yong Andrew Wong","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 2","pages":"57-59"},"PeriodicalIF":5.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9136717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factors associated with deep infiltrating endometriosis, adenomyosis and ovarian endometrioma. 与深度浸润性子宫内膜异位症、子宫腺肌病和卵巢子宫内膜异位瘤相关的因素。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.47102/annals-acadmedsg.2022334
Xi-wei Yuan, B. W. Wong, N. Randhawa, Thu PP Win, Y. Chan, Li Ma, E. Yong
INTRODUCTIONTo compare epidemiological features and clinical presentations of deep infiltrating endometriosis with endometrioma and adenomyosis, as well as to identify risk factors for the respective histologically confirmed conditions.METHODPatients undergoing index surgery at the National University Hospital, Singapore for endometriosis or adenomyosis over a 7-year period-from 2015 to 2021-were identified from hospital databases using the Table of Surgical Procedures coding. Social and epidemiological features of cases with histologically confirmed diagnoses of endometrioma only, adenomyosis only, and deep infiltrating endometriosis were compared. Significant variables from univariate analysis were entered into 3 binary multivariate logistic regression models to obtain independent risk factors for: deep infiltrating endometriosis versus endometrioma only, deep infiltrating endometriosis versus adenomyosis only, and adenomyosis only versus endometrioma only.RESULTSA total of 258 patients were included with 59 ovarian endometrioma only, 47 adenomyosis only, and 152 deep infiltrating endometrioses. Compared to endometrioma only, deep infiltrating endometriosis was associated with higher rates of severe dysmenorrhoea (odds ratio [OR] 2.80, 95% confidence interval [CI] 1.02-7.70) and out-of-pocket private surgical care (OR 4.72, 95% CI 1.85-12.04). Compared to adenomyosis only, deep infiltrating endometriosis was associated with a higher fertility desire (OR 13.47, 95% CI 1.01-180.59) and a lower body mass index (OR 0.89, 95% CI 0.79-0.99). In contrast, heavy menstrual bleeding was the hallmark of adenomyosis, being less common in patients with endometriosis.CONCLUSIONDeep infiltrating endometriosis is associated with severe dysmenorrhoea, pain related to urinary and gastrointestinal tracts, higher fertility desire and infertility rate. Patients with pain symptomatology and subfertility should be referred early to a tertiary centre with the capability to diagnose and manage deep infiltrating endometriosis.
目的:比较深浸润性子宫内膜异位症与子宫内膜异位症和子宫腺肌症的流行病学特征和临床表现,并确定各自组织学证实的危险因素。方法使用手术程序表编码从医院数据库中识别2015年至2021年7年间在新加坡国立大学医院接受子宫内膜异位症或子宫腺肌症手术的患者。比较组织学确诊为单纯子宫内膜异位症、单纯子宫内膜异位症和深浸润性子宫内膜异位症的社会和流行病学特征。将单因素分析的显著变量纳入3个二元多因素logistic回归模型,获得深度浸润性子宫内膜异位症与单纯子宫内膜异位症、深度浸润性子宫内膜异位症与单纯子宫腺肌症、单纯子宫腺肌症与单纯子宫内膜异位症的独立危险因素。结果共纳入258例患者,其中卵巢子宫内膜异位症59例,子宫内膜异位症47例,深浸润性子宫内膜异位症152例。与单纯的子宫内膜异位症相比,深度浸润性子宫内膜异位症与更高的严重痛经发生率(比值比[OR] 2.80, 95%可信区间[CI] 1.02-7.70)和自费私人手术护理(比值比[OR] 4.72, 95% CI 1.85-12.04)相关。与仅子宫腺肌症相比,深度浸润性子宫内膜异位症与较高的生育意愿(OR 13.47, 95% CI 1.01-180.59)和较低的体重指数(OR 0.89, 95% CI 0.79-0.99)相关。相比之下,大量月经出血是子宫腺肌症的标志,在子宫内膜异位症患者中不太常见。结论深浸润性子宫内膜异位症伴严重痛经、泌尿道及胃肠道疼痛、生育意愿高、不孕率高。有疼痛症状和生育能力低下的患者应尽早转诊到有能力诊断和处理深浸润性子宫内膜异位症的三级中心。
{"title":"Factors associated with deep infiltrating endometriosis, adenomyosis and ovarian endometrioma.","authors":"Xi-wei Yuan, B. W. Wong, N. Randhawa, Thu PP Win, Y. Chan, Li Ma, E. Yong","doi":"10.47102/annals-acadmedsg.2022334","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022334","url":null,"abstract":"INTRODUCTION\u0000To compare epidemiological features and clinical presentations of deep infiltrating endometriosis with endometrioma and adenomyosis, as well as to identify risk factors for the respective histologically confirmed conditions.\u0000\u0000\u0000METHOD\u0000Patients undergoing index surgery at the National University Hospital, Singapore for endometriosis or adenomyosis over a 7-year period-from 2015 to 2021-were identified from hospital databases using the Table of Surgical Procedures coding. Social and epidemiological features of cases with histologically confirmed diagnoses of endometrioma only, adenomyosis only, and deep infiltrating endometriosis were compared. Significant variables from univariate analysis were entered into 3 binary multivariate logistic regression models to obtain independent risk factors for: deep infiltrating endometriosis versus endometrioma only, deep infiltrating endometriosis versus adenomyosis only, and adenomyosis only versus endometrioma only.\u0000\u0000\u0000RESULTS\u0000A total of 258 patients were included with 59 ovarian endometrioma only, 47 adenomyosis only, and 152 deep infiltrating endometrioses. Compared to endometrioma only, deep infiltrating endometriosis was associated with higher rates of severe dysmenorrhoea (odds ratio [OR] 2.80, 95% confidence interval [CI] 1.02-7.70) and out-of-pocket private surgical care (OR 4.72, 95% CI 1.85-12.04). Compared to adenomyosis only, deep infiltrating endometriosis was associated with a higher fertility desire (OR 13.47, 95% CI 1.01-180.59) and a lower body mass index (OR 0.89, 95% CI 0.79-0.99). In contrast, heavy menstrual bleeding was the hallmark of adenomyosis, being less common in patients with endometriosis.\u0000\u0000\u0000CONCLUSION\u0000Deep infiltrating endometriosis is associated with severe dysmenorrhoea, pain related to urinary and gastrointestinal tracts, higher fertility desire and infertility rate. Patients with pain symptomatology and subfertility should be referred early to a tertiary centre with the capability to diagnose and manage deep infiltrating endometriosis.","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 2 1","pages":"71-79"},"PeriodicalIF":5.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44760100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune and coagulation profiles in 3 adults with multisystem inflammatory syndrome. 3例成人多系统炎症综合征的免疫和凝血分析
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-02-01 DOI: 10.47102/annals-acadmedsg.2022290
Ruth Xian Lynn Yap, B. P. Leung, H. Howe, Mung Ee Loh, B. Young, B. Fan, X. Lim
INTRODUCTIONThere is a paucity of information on the cytokine, complement, endothelial activation, and coagulation profiles of multisystem inflammatory syndrome in adults (MIS-A), a rare but serious complication following recovery from SARS-CoV-2 infection. We aim to examine the immune biomarker and coagulation profiles in association with the clinical presentation and course of MIS-A.METHODThe clinical features of MIS-A patients admitted to our tertiary hospital were documented. Their levels of interleukin (IL)-1β, IL-6, IL-10, IL-17, IL-18, interferon-α (IFN-α), IFN-γ, interferon gamma-induced protein 10 (IP-10), tumour necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, complement activation product (complement 5a [C5a]), and endothelial biomarker intercellular adhesion molecule-1 (ICAM-1) levels were assayed. The haemostatic profile was assessed with standard coagulation testing and thromboelastography.RESULTSThree male patients were diagnosed with MIS-A at our centre from January to June 2022 with a median age of 55 years. All had tested positive for SARS-CoV-2 12-62 days prior to MIS-A presentation, with gastrointestinal and cardiovascular systems as the most commonly involved. Levels of IL-6, IL-10, IL-18, IP-10 and MCP-1 were raised whereas IL-1β, IFN-α, IFN-γ, IL-17 and TNF-α remained normal. Markedly elevated levels of C-reactive protein (CRP), ferritin and ICAM-1 were present in all. C5a was elevated in 2 patients. A hypercoagulable state was demonstrated by raised levels of D-dimer, factor VIII, von Willebrand factor antigen, and ristocetin cofactor with corresponding raised parameters in thromboelastography in the 2 patients who had their coagulation profile assessed.CONCLUSIONMIS-A patients demonstrate activation of pro-inflammatory cytokines, endotheliopathy, complement hyperactivation and hypercoagulability.
成人多系统炎症综合征(MIS-A)是一种罕见但严重的SARS-CoV-2感染后恢复的并发症,目前关于MIS-A的细胞因子、补体、内皮活化和凝血谱的信息缺乏。我们的目的是检查与MIS-A的临床表现和病程相关的免疫生物标志物和凝血特征。方法记录我院三级医院收治的misa患者的临床特点。检测各组白细胞介素(IL)-1β、IL-6、IL-10、IL-17、IL-18、干扰素-α (IFN-α)、IFN-γ、干扰素γ诱导蛋白10 (IP-10)、肿瘤坏死因子(TNF)-α、单核细胞趋化蛋白(MCP)-1、补体激活产物(补体5a [C5a])和内皮生物标志物细胞间粘附分子-1 (ICAM-1)水平。通过标准凝血试验和血栓弹性成像评估止血情况。结果2022年1月至6月在我中心确诊为misa的男性患者3例,中位年龄55岁。在mi - a症状出现前12-62天,所有人的SARS-CoV-2检测均呈阳性,胃肠道和心血管系统是最常见的。IL-6、IL-10、IL-18、IP-10和MCP-1水平升高,而IL-1β、IFN-α、IFN-γ、IL-17和TNF-α水平保持正常。c反应蛋白(CRP)、铁蛋白和ICAM-1水平均显著升高。2例患者C5a升高。在2例进行凝血分析的患者中,d -二聚体、凝血因子VIII、血管性血友病因子抗原和雷斯托霉素辅助因子水平升高,并伴有相应的凝血弹性成像参数升高,表明患者处于高凝状态。结论:a型糖尿病患者表现出促炎细胞因子活化、内皮病变、补体过度活化和高凝性。
{"title":"Immune and coagulation profiles in 3 adults with multisystem inflammatory syndrome.","authors":"Ruth Xian Lynn Yap, B. P. Leung, H. Howe, Mung Ee Loh, B. Young, B. Fan, X. Lim","doi":"10.47102/annals-acadmedsg.2022290","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022290","url":null,"abstract":"INTRODUCTION\u0000There is a paucity of information on the cytokine, complement, endothelial activation, and coagulation profiles of multisystem inflammatory syndrome in adults (MIS-A), a rare but serious complication following recovery from SARS-CoV-2 infection. We aim to examine the immune biomarker and coagulation profiles in association with the clinical presentation and course of MIS-A.\u0000\u0000\u0000METHOD\u0000The clinical features of MIS-A patients admitted to our tertiary hospital were documented. Their levels of interleukin (IL)-1β, IL-6, IL-10, IL-17, IL-18, interferon-α (IFN-α), IFN-γ, interferon gamma-induced protein 10 (IP-10), tumour necrosis factor (TNF)-α, monocyte chemoattractant protein (MCP)-1, complement activation product (complement 5a [C5a]), and endothelial biomarker intercellular adhesion molecule-1 (ICAM-1) levels were assayed. The haemostatic profile was assessed with standard coagulation testing and thromboelastography.\u0000\u0000\u0000RESULTS\u0000Three male patients were diagnosed with MIS-A at our centre from January to June 2022 with a median age of 55 years. All had tested positive for SARS-CoV-2 12-62 days prior to MIS-A presentation, with gastrointestinal and cardiovascular systems as the most commonly involved. Levels of IL-6, IL-10, IL-18, IP-10 and MCP-1 were raised whereas IL-1β, IFN-α, IFN-γ, IL-17 and TNF-α remained normal. Markedly elevated levels of C-reactive protein (CRP), ferritin and ICAM-1 were present in all. C5a was elevated in 2 patients. A hypercoagulable state was demonstrated by raised levels of D-dimer, factor VIII, von Willebrand factor antigen, and ristocetin cofactor with corresponding raised parameters in thromboelastography in the 2 patients who had their coagulation profile assessed.\u0000\u0000\u0000CONCLUSION\u0000MIS-A patients demonstrate activation of pro-inflammatory cytokines, endotheliopathy, complement hyperactivation and hypercoagulability.","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 2 1","pages":"80-87"},"PeriodicalIF":5.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48787655","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Ablation therapies for paroxysmal atrial fibrillation: A systematic review and patient-level network meta-analysis 阵发性心房颤动的消融治疗:一项系统综述和患者水平网络荟萃分析
4区 医学 Q2 Medicine Pub Date : 2023-01-30 DOI: 10.47102/annals-acadmedsg.2022326
Khi Yung Fong, Joseph J Zhao, Yiong Huak Chan, Yue Wang, Colin Yeo, Vern Hsen Tan
Despite promising trials, catheter ablation is still regarded as an adjunct to antiarrhythmic drugs (AADs) in the treatment of paroxysmal atrial fibrillation (PAF). This study aimed to compare the effectiveness of various ablation therapies and AADs.Randomised controlled trials or propensity score-matched studies comparing atrial tachyarrhythmia recurrence among any combination of ablation modalities or AAD were retrieved. Kaplan-Meier curves and risk tables for this outcome were graphically reconstructed to extract patient-level data. Frequentist network meta-analysis (NMA) using derived hazard ratios (HRs), as well as 2 restricted mean survival time (RMST) NMAs, were conducted. Treatment strategies were ranked using P-scores.Across 24 studies comparing 6 ablation therapies (5,132 patients), Frequentist NMA-derived HRs of atrial fibrillation recurrence compared to AAD were 0.35 (95% confidence interval [CI]=0.25-0.48) for cryoballoon ablation (CBA), 0.34 (95% CI=0.25-0.47) for radiofrequency ablation (RFA), 0.14 (95% CI=0.07-0.30) for combined CBA and RFA, 0.20 (95% CI=0.10-0.41) for hot-balloon ablation, 0.43 (95% CI=0.15-1.26) for laser-balloon ablation (LBA), and 0.33 (95% CI=0.18-0.62) for pulmonary vein ablation catheter. RMST-based NMAs similarly showed significant benefit of all ablation therapies over AAD. The combination of CBA + RFA showed promising long-term superiority over CBA and RFA, while LBA showed favourable short-term efficacy.The advantage of ablation therapies over AAD in preventing atrial tachyarrhythmia recurrence suggests that ablation should be considered as the first-line treatment for PAF in patients fit for the procedure. The promising nature of several specific therapies warrants further trials to elicit their long-term efficacy and perform a cost-benefit analysis.
尽管有很好的试验,导管消融仍然被认为是抗心律失常药物(AADs)治疗阵发性心房颤动(PAF)的辅助手段。本研究旨在比较各种消融治疗和AADs的有效性。检索了随机对照试验或倾向评分匹配研究,比较任何消融方式或AAD组合的心房速搏复发。该结果的Kaplan-Meier曲线和风险表被图形化重建以提取患者水平的数据。使用衍生风险比(HRs)和2个限制平均生存时间(RMST) NMA进行频率网络meta分析(NMA)。使用p分数对治疗策略进行排名。在比较6种消融疗法(5132例患者)的24项研究中,与AAD相比,高频nma衍生的房颤复发hr为:冷冻球囊消融(CBA) 0.35(95%可信区间[CI]=0.25-0.48),射频消融(RFA) 0.34(95%可信区间[CI]= 0.25-0.47), CBA和RFA联合治疗0.14 (95% CI=0.07-0.30),热球消融0.20 (95% CI=0.10-0.41),激光球囊消融(LBA) 0.43 (95% CI=0.15-1.26)。肺静脉消融导管为0.33 (95% CI=0.18-0.62)。基于rmst的NMAs同样显示出所有消融治疗对AAD的显著益处。CBA + RFA的远期疗效优于CBA + RFA,而LBA的远期疗效优于CBA + RFA。消融术在预防房性心动过速复发方面优于AAD的优势表明,对于适合该手术的PAF患者,应考虑将消融术作为一线治疗方法。一些特定疗法的前景值得进一步的试验,以引出它们的长期疗效并进行成本效益分析。
{"title":"Ablation therapies for paroxysmal atrial fibrillation: A systematic review and patient-level network meta-analysis","authors":"Khi Yung Fong, Joseph J Zhao, Yiong Huak Chan, Yue Wang, Colin Yeo, Vern Hsen Tan","doi":"10.47102/annals-acadmedsg.2022326","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022326","url":null,"abstract":"Despite promising trials, catheter ablation is still regarded as an adjunct to antiarrhythmic drugs (AADs) in the treatment of paroxysmal atrial fibrillation (PAF). This study aimed to compare the effectiveness of various ablation therapies and AADs.Randomised controlled trials or propensity score-matched studies comparing atrial tachyarrhythmia recurrence among any combination of ablation modalities or AAD were retrieved. Kaplan-Meier curves and risk tables for this outcome were graphically reconstructed to extract patient-level data. Frequentist network meta-analysis (NMA) using derived hazard ratios (HRs), as well as 2 restricted mean survival time (RMST) NMAs, were conducted. Treatment strategies were ranked using P-scores.Across 24 studies comparing 6 ablation therapies (5,132 patients), Frequentist NMA-derived HRs of atrial fibrillation recurrence compared to AAD were 0.35 (95% confidence interval [CI]=0.25-0.48) for cryoballoon ablation (CBA), 0.34 (95% CI=0.25-0.47) for radiofrequency ablation (RFA), 0.14 (95% CI=0.07-0.30) for combined CBA and RFA, 0.20 (95% CI=0.10-0.41) for hot-balloon ablation, 0.43 (95% CI=0.15-1.26) for laser-balloon ablation (LBA), and 0.33 (95% CI=0.18-0.62) for pulmonary vein ablation catheter. RMST-based NMAs similarly showed significant benefit of all ablation therapies over AAD. The combination of CBA + RFA showed promising long-term superiority over CBA and RFA, while LBA showed favourable short-term efficacy.The advantage of ablation therapies over AAD in preventing atrial tachyarrhythmia recurrence suggests that ablation should be considered as the first-line treatment for PAF in patients fit for the procedure. The promising nature of several specific therapies warrants further trials to elicit their long-term efficacy and perform a cost-benefit analysis.","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135441244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical outcome of bacterial endogenous endophthalmitis in 15 patients. 细菌性内源性眼内炎15例临床观察。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-01-01
Catherina J Goenadi, Kean Lee Chew, Lingam Gopal, David Z Chen
{"title":"Clinical outcome of bacterial endogenous endophthalmitis in 15 patients.","authors":"Catherina J Goenadi,&nbsp;Kean Lee Chew,&nbsp;Lingam Gopal,&nbsp;David Z Chen","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 1","pages":"44-47"},"PeriodicalIF":5.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9255480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation. 导管消融作为阵发性心房颤动的一线治疗。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-01-01
Xuanming Pung, Chi Keong Ching
{"title":"Catheter ablation as first-line treatment for paroxysmal atrial fibrillation.","authors":"Xuanming Pung,&nbsp;Chi Keong Ching","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 1","pages":"6-7"},"PeriodicalIF":5.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9255484","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination and surveillance: Two basic tools for a final poliomyelitis eradication. 疫苗接种和监测:最终消灭脊髓灰质炎的两个基本工具。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.47102/annals-acadmedsg.20236
R. Rüttimann
{"title":"Vaccination and surveillance: Two basic tools for a final poliomyelitis eradication.","authors":"R. Rüttimann","doi":"10.47102/annals-acadmedsg.20236","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.20236","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 1 1","pages":"1-2"},"PeriodicalIF":5.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45626336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical outcome of bacterial endogenous endophthalmitis in 15 patients. 细菌性内源性眼内炎15例临床观察。
IF 5.2 4区 医学 Q2 Medicine Pub Date : 2023-01-01 DOI: 10.47102/annals-acadmedsg.2022407
C. J. Goenadi, K. L. Chew, L. Gopal, David Z Chen
{"title":"Clinical outcome of bacterial endogenous endophthalmitis in 15 patients.","authors":"C. J. Goenadi, K. L. Chew, L. Gopal, David Z Chen","doi":"10.47102/annals-acadmedsg.2022407","DOIUrl":"https://doi.org/10.47102/annals-acadmedsg.2022407","url":null,"abstract":"","PeriodicalId":50774,"journal":{"name":"Annals Academy of Medicine Singapore","volume":"52 1 1","pages":"44-47"},"PeriodicalIF":5.2,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43049087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals Academy of Medicine Singapore
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1